Finasteride Cost in Michigan 2026

What Does Finasteride Actually Cost in Michigan Right Now?

Generic finasteride runs about $12 per month at Michigan retail pharmacies in 2026 when you pay cash. Brand-name Propecia carries a list price near $85 per month, but almost no one paying out-of-pocket needs to spend that. GoodRx and similar discount cards routinely bring the retail price below $15 at chains including CVS, Walgreens, Meijer, and Kroger pharmacies throughout the state.

The price gap between brand and generic exists because finasteride's core patents expired years ago, opening manufacturing to multiple generic producers. The FDA requires generic manufacturers to demonstrate bioequivalence to the reference listed drug before approval, so a $12 generic tablet delivers the same active molecule at the same dose as Propecia [1].

A 90-day supply tends to cost less per unit than a 30-day fill. At Costco and Sam's Club pharmacies in Michigan, a 90-tablet supply of 1 mg generic finasteride has been quoted at roughly $25 to $30 without any coupon, which works out to approximately $8 to $10 per month [2]. Mailing-address GoodRx coupons have pushed prices as low as $7 per month at select Michigan locations.

Prices vary by zip code. Urban Detroit-area pharmacies sometimes quote lower prices due to higher competition, while rural Upper Peninsula pharmacies may quote slightly higher without coupon intervention.

Michigan Medicaid Coverage for Finasteride

Michigan Medicaid (Healthy Michigan Plan and traditional Medicaid) covers finasteride for both androgenetic alopecia (AGA) and benign prostatic hyperplasia (BPH), but requires prior authorization (PA) in most cases. The PA process asks the prescribing clinician to document the diagnosis, confirm appropriate dosing, and attest that the patient meets medical necessity criteria.

The Michigan Department of Health and Human Services publishes its preferred drug list annually. Finasteride appears as a covered generic under the urologic and dermatologic categories [3]. For BPH specifically, coverage is more straightforward because the 5 mg dose has a clear symptom-based indication. AGA prior authorization sometimes requires documentation that the hair loss is consistent with male-pattern presentation and that the patient has discussed sexual side-effect risks with their provider.

Medicaid managed care plans operating in Michigan, including Molina, McLaren Health Plan, and Priority Health, each administer their own PA forms, but all are bound by the state formulary. Approval timelines average 3 to 5 business days when documentation is complete. An expedited PA, available when clinical urgency exists, must be adjudicated within 24 hours under Michigan Administrative Code [4].

Patients who are denied can appeal. The Michigan Medicaid appeals process includes an informal reconsideration step, followed by a formal hearing if needed. Clinicians at HealthRX can submit PA paperwork and appeal letters on a patient's behalf.

Is Compounded Finasteride Legal in Michigan?

Compounded finasteride is legal in Michigan when prepared by a state-licensed 503A pharmacy operating under a valid patient-specific prescription. The FDA distinguishes 503A pharmacies, which compound for individual patients, from 503B outsourcing facilities, which produce larger batches [5]. Both types may legally compound finasteride in Michigan as long as the drug is not on the FDA's "essentially a copy" list and a valid prescriber-patient relationship exists.

Michigan's Board of Pharmacy regulates 503A pharmacies under the Public Health Code (MCL 333.17748). A pharmacy must hold an active Michigan license, compound under USP <795> standards for non-sterile preparations, and dispense only pursuant to a valid prescription [6]. Buying compounded finasteride from an unlicensed out-of-state vendor without a prescription is not legal and poses safety risks including uncertain potency.

Compounded finasteride typically costs around $45 per month in Michigan. That figure reflects custom formulations, sometimes in topical gel or liquid drop form rather than oral tablet, which some patients prefer for localized application to the scalp. Topical finasteride at concentrations of 0.1% to 0.25% in a vehicle such as minoxidil solution has been studied as a strategy to reduce systemic absorption [7]. A 2020 pilot study published in JAMA Dermatology found that topical finasteride 0.25% solution produced scalp tissue concentrations comparable to 1 mg oral dosing while keeping serum dihydrotestosterone (DHT) suppression lower than the oral route, though the clinical long-term significance of that difference is still being evaluated [8].

How Finasteride Works and What the Evidence Shows

Finasteride is a type II 5-alpha reductase inhibitor. It blocks the enzyme that converts testosterone to dihydrotestosterone (DHT), the androgen primarily responsible for miniaturizing hair follicles in genetically susceptible individuals and for driving prostate tissue growth [9].

DHT suppression is dose-dependent. The 1 mg oral dose suppresses serum DHT by approximately 70%, while the 5 mg dose suppresses it by roughly 70 to 75% [10]. The marginal difference between doses explains why 5 mg is reserved for BPH, where prostate volume reduction requires sustained high-level suppression, while 1 mg is sufficient for AGA.

Kaufman et al. (J Am Acad Dermatol 1998, N=1,553) demonstrated that finasteride 1 mg daily over 2 years produced statistically significant increases in hair count versus placebo, with 83% of men receiving finasteride maintaining or increasing hair count compared to 28% in the placebo group [11]. That trial remains a foundational reference for AGA prescribing. The FDA approved Propecia (finasteride 1 mg) for male AGA in 1997 based on this and related data [12].

For BPH, the PLESS trial (N=3,040) showed finasteride 5 mg over 4 years reduced the risk of acute urinary retention by 57% and the need for BPH-related surgery by 55% compared to placebo [13]. The American Urological Association's 2021 BPH guidelines cite finasteride as a first-line pharmacologic option for men with enlarged prostates [14].

Which Insurance Plans Cover Finasteride in Michigan?

Most commercial insurance plans sold in Michigan cover generic finasteride at Tier 1 or Tier 2 on their formularies, which typically means a $5 to $20 copay per 30-day fill. Blue Cross Blue Shield of Michigan, Priority Health, HAP (Health Alliance Plan), and Aetna all list generic finasteride on their 2026 standard formularies [15].

Coverage criteria differ by indication. BPH coverage is almost universally straightforward because it is an FDA-approved indication with clear ICD-10 coding (N40.1 for BPH with lower urinary tract symptoms). AGA coverage is more variable. Some plans classify AGA as a cosmetic condition and exclude it, while others cover it under their dermatology benefit. Checking your specific plan's Evidence of Coverage document before filling the prescription avoids surprise charges.

Employer-sponsored self-insured plans (common among large Michigan manufacturers like automotive companies) set their own formularies. A benefits coordinator or HR department can confirm coverage. COBRA participants retain the same formulary as the active-employee plan for the duration of COBRA coverage.

Medicare Part D covers finasteride for BPH in most plans because it meets the "medically necessary" threshold. AGA is typically excluded under Medicare because hair loss is categorized as cosmetic under CMS guidelines [16]. Patients on Medicare Advantage should check their plan's Part D formulary directly.

How to Use Discount Programs and Savings Cards in Michigan

The cheapest out-of-pocket path for most uninsured or underinsured Michigan residents is a GoodRx or RxSaver coupon combined with a 90-day supply at a high-volume pharmacy. Prices fluctuate weekly based on pharmacy contracts, so comparing three or four options before filling is worthwhile.

Merck does not currently offer a widely available savings card for generic finasteride because Propecia's patent has expired. For patients still prescribed brand-name Propecia, Merck's patient assistance program may apply to those below income thresholds, typically 400% of the federal poverty level [17]. The NeedyMeds database lists current eligibility criteria and application links for Michigan residents [18].

Mark Cuban's Cost Plus Drugs (costplusdrugs.com) lists finasteride 1 mg at approximately $5 for 30 tablets as of early 2025, shipping to Michigan. That price reflects the platform's transparent markup model and does not require insurance [19]. The prescription must still originate from a licensed Michigan prescriber.

Manufacturer patient assistance programs for brand Proscar (finasteride 5 mg) are available through Merck Helps. Income and residency documentation is required. Michigan residents can apply online or through a social worker at their healthcare facility.

Telehealth Prescribing of Finasteride in Michigan

Telehealth prescribing of finasteride is fully legal in Michigan. The Michigan Telehealth Act (PA 225 of 2016) established that a valid prescriber-patient relationship can be formed via synchronous audio-video consultation, meaning no in-person visit is required to obtain a finasteride prescription [20].

Prescribers must hold an active Michigan license or a Michigan telehealth registration. HealthRX clinicians licensed in Michigan conduct asynchronous and synchronous consultations, review uploaded photos for AGA diagnosis, and send prescriptions directly to the patient's preferred Michigan pharmacy or mail the prescription to a preferred mail-order pharmacy.

The consultation typically involves a short intake questionnaire covering personal and family history of hair loss, current medications (to check for interactions), and a review of finasteride's known side-effect profile, which includes sexual dysfunction in approximately 3.4 to 3.8% of men in controlled trials at 1 mg [21]. The FDA requires a patient medication guide be dispensed with each fill [22].

Patients with a history of prostate cancer, liver disease, or hypersensitivity to finasteride or dutasteride are not candidates for telehealth-only prescribing and require in-person workup.

Understanding the Cost Breakdown: Generic vs. Brand vs. Compounded

Three pricing tiers exist for Michigan patients in 2026.

Generic oral finasteride at $12 per month is the most cost-effective option for the majority of patients with AGA or BPH who tolerate oral tablets. Bioequivalence to Propecia is FDA-confirmed [1].

Brand-name Propecia at $85 per month offers no clinical advantage over generic for most patients. The only reason to choose it would be a documented adverse reaction to a specific generic's inactive ingredients, which is rare.

Compounded finasteride at roughly $45 per month occupies a middle tier and makes most sense when a patient wants topical delivery to reduce systemic DHT suppression, or when a customized dose or vehicle is clinically indicated. The higher price reflects pharmacy labor and custom formulation, not superior bioavailability. Patients should confirm their 503A pharmacy's Michigan license before ordering.

The HealthRX Michigan Finasteride Cost Decision Framework recommends the following pathway: start with a GoodRx price check at three local pharmacies; if the cash price exceeds $20 per month, verify insurance tier before filling; if uninsured and cost exceeds $15, compare Cost Plus Drugs and GoodRx mail-order options; only consider compounded finasteride when topical delivery is clinically indicated or when a formulary restriction prevents oral generic access.

Side Effects and Monitoring Considerations That Affect Long-Term Cost

Monitoring requirements influence the total cost of finasteride therapy, not just the prescription price.

A baseline PSA (prostate-specific antigen) test is recommended before starting finasteride in men over 40 because finasteride lowers PSA by approximately 50% after 6 months of treatment, which could mask a rising PSA signal for prostate cancer [23]. Michigan Medicare and most commercial plans cover PSA screening annually, so this does not add out-of-pocket cost for most insured patients.

Liver function testing is not routinely required for finasteride at approved doses, distinguishing it from some other systemic medications used in dermatology [24]. That limits lab costs to PSA monitoring for most patients.

Post-finasteride syndrome (PFS) is a contested diagnosis describing persistent sexual, neurological, and physical symptoms after stopping finasteride. The FDA added a label warning in 2012 [25]. Patients who report persistent symptoms after discontinuation may require additional specialist evaluation, adding downstream costs that are difficult to predict at the time of prescribing.

Drug Interactions and Contraindications Relevant to Michigan Prescribing

Finasteride has minimal cytochrome P450 interactions because it is metabolized primarily by CYP3A4 but does not strongly inhibit or induce that pathway at therapeutic doses [26]. Clinically significant pharmacokinetic interactions with common medications, including metformin, lisinopril, and atorvastatin, have not been demonstrated in published interaction studies.

The drug is absolutely contraindicated in women who are or may become pregnant because of the risk of external genital abnormalities in a male fetus [27]. Michigan Medicaid and commercial plans will not cover finasteride for female patients outside of specific off-label indications documented by a dermatologist or endocrinologist, such as hyperandrogenic alopecia in postmenopausal women.

Dutasteride (Avodart), a dual 5-alpha reductase inhibitor, is sometimes prescribed off-label for AGA when finasteride response is inadequate. It carries similar cost structures and the same Michigan Medicaid PA requirements [28]. Switching from finasteride to dutasteride under an existing insurance approval typically requires a new PA submission.

What Michigan Patients Should Ask at Their First Appointment

Before the first prescription is written, four questions reliably reduce confusion and downstream cost.

Ask whether the prescriber is sending a 90-day supply, because that fill typically costs less per tablet and reduces pharmacy trip frequency. Ask whether the prescription is for brand or generic, because a DAW-1 (dispense as written) code blocks generic substitution and will raise costs significantly at most Michigan pharmacies. Confirm whether a GoodRx coupon or manufacturer savings card should be applied, because insurance and discount cards cannot be combined, and sometimes the cash-pay coupon price is lower than the insurance copay for a Tier 2 drug. Request the medication guide, which the pharmacist is required by FDA to provide but sometimes omits for refill prescriptions [22].

A follow-up at 12 months is standard practice. Hair count and global photographic assessment at baseline and 12 months allows the clinician to objectively measure response. The Kaufman et al. trial used standardized photography and hair counts in a 1 cm² target area; replicating that methodology in practice provides objective data to justify continued therapy to an insurer if a re-authorization is needed [11].

Finasteride's full efficacy on hair density typically becomes visible by month 12, with peak response at 24 months in the two-year Kaufman data [11]. Patients who discontinue before 12 months are likely abandoning therapy before peak benefit, which is a common and preventable outcome when cost is a barrier.